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Background: Ischemia is the major cause of acute kidney injury (AKI), associated with high mortality and morbidity.
Mesenchymal stem cells (MSCs) have multilineage differentiation potential and can be a potent therapeutic option
for the cure of AKI.
Methods: MSCs were cultured in four groups SNAP (S-nitroso N-acetyl penicillamine), SNAP + Methylene Blue (MB),
MB and a control for in vitro analysis. Cultured MSCs were pre-conditioned with either SNAP (100 μM) or MB (1 μM)
or both for 6 hours. Renal ischemia was induced in four groups (as in in vitro study) of rats by clamping the left
renal padicle for 45 minutes and then different pre-conditioned stem cells were transplanted.
Results: We report that pre-conditioning of MSCs with SNAP enhances their proliferation, survival and engraftment
in ischemic kidney. Rat MSCs pre-conditioned with SNAP decreased cell apoptosis and increased proliferation and
cytoprotective genes’ expression in vitro. Our in vivo data showed enhanced survival and engraftment, proliferation,
reduction in fibrosis, significant improvement in renal function and higher expression of pro-survival and
pro-angiogenic factors in ischemic renal tissue in SNAP pre-conditioned group of animals. Cytoprotective effects of
SNAP pre-conditioning were abrogated by MB, an inhibitor of nitric oxide synthase (NOS) and guanylate cyclase.
Conclusion: The results of these studies demonstrate that SNAP pre-conditioning might be useful to enhance
therapeutic potential of MSCs in attenuating renal ischemia reperfusion injury.
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The mammalian kidney has multifarious functions, includ-
ing maintenance of blood pressure, regulation of pH and
other metabolic processes, such as elimination of nitrogen-
ous wastes and synthesis and release of endocrine factors.
Loss of regional or total blood flow to the kidney often
happens in shock, sepsis and during renal transplantation,
can lead to acute kidney injury (AKI). Inflammatory
process and primary ischemic injury in vascular cells
results in prolonged localized ischemia that substantially
increases severity of injury in affected areas. During* Correspondence: masoudshareef@gmail.com
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reproduction in any medium, provided the orischemia, the endothelium produces free radicals and
secretes chemo-attractants which upon reperfusion seques-
ter and activate neutrophils and intensification of the injury
[1]. AKI associated mortality is estimated as 50% in hospi-
talized patients and 70-80% in patients under intensive
care [2,3]. Currently, the therapeutic choices are confined
to supportive measures and preventive strategies. None of
these have shown a decrease in mortality rate caused by
AKI. Kidney transplant is an alternate option but scarcity
of donor; high cost and immune rejection limits its utility.
It is therefore imperative to find other therapeutic options
that could regenerate the tubular epithelium, restore kid-
ney function and reverse the effects of AKI.
MSCs are multi-potent cell population residing in
bone marrow. These are capable of differentiating into
cell types other than their tissue of origin. In culture,l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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adhere to the plastic surface and exhibit fibroblast like
morphology [4]. Moreover MSCs secrete an array of
growth factors as vascular endothelial growth factor
(VEGF), insulin like growth factor-1 (IGF-1), hepatocyte
growth factor (HGF) and anti-apoptotic cytokines [5].
The therapeutic effects of MSCs after transplantation
are dependent on their survival in the recipient tissue.
Taking into account that prolonged cell survival may
augment the usefulness of stem cell therapy. It has been
reported that pre-conditioning of different tissues by a
prior stimulus provides protection against injury [6].
The most extensively studied pre-conditioning stimulus
is brief sub-injurious ischemia, which induces protection
against subsequent ischemic injury [7]. Similar protect-
ive effects can also be triggered by growth factors, cyto-
kines or with some pharmacological agents [5,8].
Nitric oxide (NO) is a free radical generated as a result
of oxidation of L-arginine catalyzed by all three isoforms
(neuronal, inducible and endothelial) of nitric oxide syn-
thase (NOS) and performs different patho-physiological
functions in different cellular environments [9-13]. It
protects macrophages, hepatocytes, cardiomyocytes
against different injuries by modifying expression of dif-
ferent genes [14]. Various donors of NO have been
implicated as cyto-protective and tissue protective fac-
tors in vivo [1,15].
This study was designed to evaluate the effects of pre-
conditioning of bone marrow derived MSCs with a
pharmacological agent S-nitroso N acetyl penicillamine
(SNAP, a NO donor) on the regenerative potential of
MSCs against oxidative and ischemic stress in kidney. We
report that SNAP pre-conditioning of MSCs improved
their potential against oxidative stress, enhanced their pro-
liferation and reduced apoptosis in vitro. Further it aug-
mented the homing of MSCs in ischemic renal
parenchyma, induced different cytoprotective and para-




The investigation conforms to the Guide for the Care
and Use of Laboratory Animals published by the US
National Institutes of Health (NIH Publication No. 85–23,
revised 1985). All animals were treated according to the
procedures approved by the Institutional Review Board
(IRB) at the National Center of Excellence in Molecular
Biology, Lahore, Pakistan.
In vitro study
Isolation of MSCs from bone marrow
MSCs were isolated on the basis of their preferential at-
tachment to plastic surface of culture flask as previouslydescribed [16]. Bone marrow MSCs were isolated by
flushing femurs and tibiae of male Sprague–Dawley rats.
The suspension was then centrifuged at 1200 rpm for
10 min at room temperature. The cells were plated in
tissue culture flask containing Iscove’s Modified Delbeco’s
Medium (IMDM, MP Biomedicals, USA) supplemented
with 20% fetal bovine serum (Sigma-Aldrich, Germany),
100ug/ml streptomycin and 100U/ml penicillin and placed
in incubator having 95% humidity and 5% CO2. The
medium was changed after three days of plating and
washed with phosphate buffered saline (PBS). The medium
was then changed after every three days. When confluency
is reached, the cells were sub-cultured in a ratio of 1:3 till
they reached 70%-80% confluency. The cells of passages
2–3 were used in the study.
Pre-conditioning of stem cells
The cells were plated in tissue culture plates in equal
number (2x105) and divided in four groups. Group 1:
control; cells incubated in normal serum free medium,
group 2: cells treated with 100uM S-nitroso N acetylpe-
nicillamine (SNAP) a NO donor, group 3: cells treated
with both 100uM SNAP and 1uM methylene blue (an
inhibitor of NOS and gyanalate cyclase) and group 4: the
cells treated with 1uM methylene blue alone (group 4).
Measurement of lactate dehydrogenase, cell viability and
apoptosis assay
Cell viability was assessed after exposing above men-
tioned groups of cells to 200μl H2O2 for 1 hour (hr).
The medium was removed and trypan blue solution
(Sigma-Aldrich, Germany) was added to the culture.
The cells were then analyzed under phase contrast
microscope [17]. The number of trypan blue positive
cells was then counted per field for each treatment.
LDH release was analyzed using cell supernatants by a
commercially available kit (Sigma-Aldrich, Germany).
Apoptosis was assessed by annexin V binding assay
(Abcam, UK). The slides were then analyzed under the
microscope (BX61 Olympus). The cells were counted
manually and percentage of annexin V positive cells was
calculated in each treatment group.
Measurement of release of nitric oxide
NO release in the culture medium was assessed from
the amount of nitrite in the medium which is a stable re-
action product of NO with molecular oxygen. 100μl of
culture supernatant was treated with equal volume of
Griess reagent (0.5% sulfanilamide, 0.05% N-1-naphthyl
ethylenediamine dihydrochloride in 2.5% H3PO4) in 96
well plate and placed on shaker for 10 min at room
temperature. The resulting color product was spectro-
photometrically quantified at 538nm.
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The effects of pre-conditioning on gene expression were
assessed by performing quantitative real-time polymer-
ase chain reaction using ABI Real-Time system 7500. All
four groups of cells were exposed to H2O2 for 1 hr and
then medium was aspirated and RNA from all four
groups of cells was extracted using TRIZOL (Invitrogen,
USA) according to the manufacturer’s instructions.
cDNA was synthesized using 1μg of total RNA from
each group by Revert Aid H Minus first strand cDNA
synthesis kit (Fermentas).
The expression of genes shown in Table 1 was ana-
lyzed through real-time quantitative PCR, stromal
derived factor-1 (SDF1), IGF1, AKT-1, VEGF, Bcl-2,
PCNA and β-actin was used as an internal control using
Maxima syber green qPCR mix (Fermentas) according
to manufacturer’s protocol on 7500 thermal cycler (Ap-
plied Biosystem, USA). The relative gene expression nor-
malized with β-actin and analysis was done by using
SDS 3.1 software provided by Applied Biosystems, USA.
In vivo study
Renal ischemic insult model
All animal procedures were according to instructions of
institutional committee for animal care. Renal ischemic
model was developed in male Sprague Dawley rats (200-
300g) by blocking the left renal pedicle. Briefly, the rats
were anesthetized with pentobarbital (40mg/kg body
weight). A left lateral abdominal incision was made ex-
posing kidney. The renal pedicle was occluded with
micro vascular clamp maintaining body temperature at
37°C. The clamp was then removed after 45 minutes








PCNA Forward, 50- GACCTCGCTCCCCTTACAGT -30
Reverse, 50- TCCAGCACCTTCTTCAGGAT -30




AKT 1 Forward, 50-CCTCAAGAACGATGGCACCT-30
Reverse, 50-CAGGCAGCGGATGATAAAGG-30
β-Actin Forward, 50- GCTGTGTTGTCCCTGTATGC-30
Reverse, 50- GAGCGCGTAACCCTCATAGA-30skin were closed with 4/0 suture. The animals were
allowed to recover and returned to their cages.
Labeling of MSCs and transplantation in ischemic kidney
To track the transplanted cells and to evaluate the yield
of transplantation in vivo, the cell suspension was la-
beled with CM-Dil (invitrogen, USA), a lipophilic dye
that binds to cell membrane irreversibly.
Male rats were divided into five groups (n=6) after in-
duction of renal ischemia to receive intra-renal paren-
chymal injection of either normal MSCs without pre-
conditioning (MCs group), or SNAP pre-conditioned
MSCs (SNAP group): methylene blue pre-conditioned
MSCs (MB group) and SNAP plus methylene blue pre-
conditioned MSCs (SNAP+MB group) and serum free
medium injected control group (control). After 45 min
ischemia to the kidney, 1.5 × 106 labeled cells in serum
free medium, were transplanted into renal parenchyma
at three different sites just after reflow to each group
described above while the control animals received
only serum free medium. The incision was closed with
suture and animals were revived and transferred to ani-
mal facility.
Collection of urine and blood
The rats were kept in metabolic cages and 24hrs urine
was collected and measured. Blood was drawn through
tail vein and serum was isolated for each rat.
Immunoflourescence staining
After 3 weeks of transplantation, animals were sacrificed
and kidneys were harvested and processed. Frozen tissue
sections (5 μm thickness) were air dried and washed
with PBS for 5 min. Sections were incubated with spe-
cific primary antibody of actin (abcam, UK) with speci-
fied dilution after non-specific blocking with 2% donkey
serum and then FITC (flourocinisothiocynate) conjua-
gated donkey anti mouse secondary antibody. The sec-
tions were counter stained with DAPI and mounted
(prolong gold anti-fade, Invitrogen, USA). Fluorescence
images were taken by Olympus BX 61 microscope with
DP 70 camera.
Immunohistochemical analysis of ischemic renal tissue
Paraffin sections of kidney from all experimental groups
were analyzed for the detection of different factors
through application of enzyme labeled polymer (Vector
ImmPRESS kit, Vector Laboratories, USA) according to
manufacturer’s instructions. Briefly, the sections were
subjected to citrate based antigen retrieval followed by
endogenous peroxidase and avidin-biotin blocking using
a Streptavidin-Biotin blocking reagent (Abcam, UK). Fol-
lowing serum blocking, sections were incubated either
for one hour at room temperature or overnight at 4°C in
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of specified dilutions: a Rabbit polyclonal anti iNOS
antibody, mouse monoclonal to VEGF, rabbit polyclonal
to Ki-67, rabbit polyclonal anti eNOS antibody (Abcam,
UK), rabbit polyclonal to IGF1 and rabbit polyclonal
Bcl-2 (Santa Cruz, USA) followed by HRP conjugated
secondary antibodies. The chromogen substrate 3, 3’-
Diaminobenzidine Tetra hydrochloride (DAB) was incu-
bated until the characteristic color was developed fol-
lowed by hematoxylin counterstaining.Measurement of collagen
Paraffin sections were stained with Sirius red to analyze
fibrosis in the tissue. The slides were analyzed under
BX61 microscope. Total collagen content was measured
as the percent of area with the help of Image J (NIH)
software.Measurement of creatinine clearance and Blood Urea
Nitrogen (BUN)
Creatinine was measured in 24 hr urine and serum of
the rats using Crea Plus kit (Roche, Germany) according
to the manufacturer’s procedure. Briefly the urine sam-
ples were diluted 1:50 and undiluted serum samples
were used. The samples were analyzed @ 546 nm test
wave length and @ 700 nm reference wave length and
creatinine values were calculated as follow:
Creatinine Clearance ¼ creatinine of urine  24hr urine
volume  1440 creatinine of
serum:
The blood urea nitrogen level in serum was measured
using a urea estimation kit (Diasys, Germany) according
to the manufacturer’s procedure. Briefly serum was iso-
lated from blood of each rat. The reagent was mixed
with samples and analyzed at 340 nm wavelength by
spectrophotometer. BUN was calculated as follow:
BUN ¼ OD of sample  concentration of standard
 0:47 OD of standard
Statistical analysis
All experiments were performed in triplicates and
repeated at least three times. Statistical significance was
analyzed using one way ANOVA followed by Bonferroni
testing through Graphpad Prism 5 software. A p-value ≤
0.05 was considered statistically significant.Results
In vitro study
Cytoprotective effects of pre-conditioning on MSCs
MSCs showed significant loss of viability when exposed to
H2O2 (200 μM) for 1 hr. After SNAP pre-conditioning,
cytotoxic effects of H2O2 were markedly decreased com-
pared to non pre-conditioned control. This effect was
diminished in SNAP/MB and MB alone groups
(Figure 1A). Likewise SNAP pre-conditioned MSCs were
distinctly protected against H2O2 as shown by decreased re-
lease of LDH as compared to control group (Figure 1B).
Apoptosis in MSCs after pre-conditioning was assessed by
annexin V staining. The percentage of annexin V positive
cells decreased from 27% in control group to 9% in SNAP
pre-conditioned group (Figure 1C). This decrease in cell
death was diminished with methylene blue treatment (22%
and 23% in SNAP/MB and MB groups respectively).
Release of nitric oxide in medium
The amount of nitrite produced as a result of reaction of
NO with molecular oxygen was estimated. Griess re-
agent was added to the medium and OD at 538 nm
wavelength was taken. Level of nitrite was significantly
high (2.59 ± 0.3 μM) in the medium of SNAP group
compared to the control (0.27 ± 0.2 μM).
Enhanced Expression of Cytoprotective, Proangiogenic and
proliferating genes after SNAP pre-conditioning
The quantitative analysis of cyto-protective and pro-
angiogenic growth factor genes by real time PCR
revealed many folds increase (2.11 ± 0.178, 2.94 ± 0.026,
2.01 ± 0.052 and 1.76 ± 0.21) in the expression of SDF1,
IGF1, Akt and VEGF respectively in SNAP pre-
conditioned group (Figure 2A and B) compared to nor-
mal MSCs, SNAP+MB and MB gourps. Similarly, B cell
lymphoma 2 (Bcl-2) a cytoprotective gene expressed
under the influence of Akt [18] was up-regulated after
SNAP pre-conditioning (Figure 2A and B).
Effect of SNAP pre-conditioning on proliferation of
MSCs was assessed by analyzing the expression of prolif-
erating cell nuclear antigen (PCNA) by real-time RT-
PCR. Significant increase in the expression of PCNA
(Figure 2A and B) was observed in SNAP treated group
(2.012 ± 0.242) when judged against control (1 ± 0.241).
In vivo studies
Pre-conditioning enhanced homing of transplanted MSCs in
ischemic renal tissue
A significant increase in the homing of CM-Dil labeled
MSCs was detected at the site of injured tubular cells in
SNAP pre-conditioned group compared to control
(22.0 ± 1.0 vs. 7.0 ± 1.0; Figure 3). The homing of MSCs
reduced to 10.0 ± 1.0 and 8.0 ± 1.0 CM-Dil positive cells
Figure 1 Effect of SNAP pre-conditioning on viability of MSCs against hypoxic injury. A: H2O2 induced cell death was decreased in SNAP
pre-condition compared to the control and other groups. B: LDH release was decreased in SNAP pre-conditioned group compared to other
treatment groups C: Annexin V staining of different pre-conditioned groups (magnification 200X). All values were expressed as mean ± SEM.
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values were expressed as mean ±SEM.
Effect of Pre-conditioning on renal function and fibrosis
Administration of SNAP pre-conditioned MSCs amelio-
rated the kidney function as assessed by sustained im-
provement in creatinine clearance (Table 2) and
decreased blood urea nitrogen levels over a period of
three weeks compared to other treatment groups.
Fibrosis in ischemic kidney tissue was analyzed by
sirius red staining which stains the fibrillar collagen
content in a tissue. Three slides per animal and six
fields per slide were analyzed for fibrosis measurement.
Figure 4 (A-F) exhibits decreased fibrillary collagen in
SNAP group compared to the other treatment groups.
Quantitative analysis performed by Image J software
(Figure 4G) indicates that pre-conditioning reduced the
fibrosis in SNAP group while no significant reduction infibrotic area was seen in other groups when compared
to the ischemic control.
Effect of Pre-conditioning on proliferation of tubular cells
The transplantation of SNAP pre-conditioned MSCs sig-
nificantly enhanced the proliferation of tubular cells as
depicted by Ki 67 expression in kidney. It was revealed
that SNAP group had numerous Ki 67 positive nuclei
compared to control group (114.0 ± 2.05 vs. 33.0 ± 2.01)
while normal MSCs group, SNAP/MB and MB groups
(Figure 5A and B) did not show such proliferation in
kidney tissue (40.0 ± 2.36, 46.0 ± 2.7 and 43.0 ± 2.1).
Pro-survival and Pro-angiogenic factors induced by
Pre-conditioned MSCs in ischemic kidney tissue
Among three isoforms of NOS inducible Nitric Oxide
Synthase (iNOS) is induced in response to different
patho-physiolocial conditions and acts independent to
Figure 2 Gene Expression Analysis of pre-conditioned MSCs. Real time PCR was performed to relatively quantify the expressions of
cytoprotective and proangiogenic genes in different groups after pre-conditioning. The expression of cytoprotective and proangiogenic genes
was more pronounced in SNAP pre-conditioned group compared to other treatment groups. A: graphical presentation of fold induction in
expression of various genes and B: agarose gel electorphoresis pictures of different genes.
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reperfusion injury in the kidney. Transplantation of
SNAP pre-conditioned MSCs in the ischemic kidney tis-
sue resulted in decreased iNOS levels compared to the
ischemic control and treatment control (Figure 5). This
decrease in the expression of iNOS was not seen in
SNAP/MB and MB groups.
Bcl-2, IGF-1 and VEGF are cyto-protective growth fac-
tors and impart a vital role in cell survival, angiogenesis
and vasculogenesis in the tissue. Expression of these fac-
tors in transplanted groups was analyzed by immunohis-
tochemical staining. SNAP pre-conditioned group
showed enhanced Bcl-2, IGF-1 and VEGF levels in is-
chemic kidney tissue compared with ischemic control,SNAP/MB and MB treated MSC transplanted groups.
Concurrently the expression of eNOS, a constitutive
form of nitric oxide synthase, expressed in endothelial
cells was also found to be increased in the ischemic kid-
ney tissue after SNAP group (Figure 5).
Discussion
Bone marrow derived MSCs have the ability to amelior-
ate renal ischemia [19]. During renal ischemia, kidney
becomes rich in reactive oxygen species, pro inflamma-
tory cytokines and factors facilitating apoptosis [20].
Transplanted MSCs encounter such harsh environment
resulting in poor survival which limits their utility in re-
generative cellular therapy for renal ischemia [21]. In an
Figure 3 Effect of pre-conditioning on homing of MSCs in ischemic renal tissue. Homing of pre-conditioned MSCs in ischemic kidney tissue
was assessed by tracking the CM-Dil positive cells under fluorescence microscope. The tissues were stained with actin (green), CM-Dil in red and
nuclei were stained with DAPI (blue). Extensive homing of the CM-Dil positive MSCs was observed in SNAP pre-conditioned group (A) while a
limited number of CM-Dil positive cells were observed in non pre-conditioned MSCs group (B). Whereas fewer MSCs were observed in
SNAP/methylne blue and methylene blue only treated groups relative to the SNAP pre-conditioned group (C & D), magnification = 200x. E is
graphical presentation of cell homing.
Table 2 Renal function (creatinine clearance and blood urea nitrogen) analysis of rats
Treatments/Parameters Creatinine clearance Blood urea nitrogen
1st Week 2nd Week 3rd Week 1st Week 2nd Week 3rd Week
NORMAL 1.148 ± 0.07 13.76 ± 1.4
CONTROL 0.358 ± 0.09 0.429 ± 0.09 0.553 ± 0.07 41.14 ± 3.04 37.77 ± 1.45 36.81 ± 1.30
N-MSC 0.480 ± 0.04 0.584 ± 0.04 0.791 ± 0.04 33.79 ± 1.40 28.88 ± 1.16 24.95 ± 1.35
SNAP 0.581 ± 0.03* 0.796 ± 0.05* 1.008 ± 0.05* 28.10 ± 1.78* 21.80 ± 1.69* 14.58 ± 1.10*
SNAP+MB 0.432 ± 0.09 0.581 ± 0.08 0.792 ± 0.05 32.93 ± 0.61 28.13 ± 1.53 23.03 ± 0.92
MB 0.425 ± 0.08 0.578 ± 0.05 0.790 ± 0.05 34.16 ± 1.73 27.86 ± 1.03 23.14 ± 1.03
*= p is equal or less than 0.05.
N-MSC= Normal MSCs; SNAP= SNAP pre-conditioned MSCs; SNAP + MB=SNAP + methylene blue treated MSCs and.
MB= Methylene blue treated MSCs.
The values are mean ± SEM and analyzed by one way ANOVA.
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Figure 4 Assessment of Fibrosis in ischemic kidney. A-F: Representative micrograph of kidney tissue stained with Sirius red showing collagen
deposition in various treatment groups (A-F) and (A= normal kidney, B= ischemic kidney, C= Normal MSCs, D= SNAP, E= SNAP + MB, F= MB
and G= graphical presentation of quantitative analysis of fibrosis). #: p < 0.05 SNAP vs MSCs, SNAP/MB and MB.
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MSCs were pre-conditioned with a NO donor SNAP.
NO is diverse biomolecule with a range of physiological
functions and importance. NO has been found cyto-
protective in vivo as well as in vitro against a variety of
cyto-toxic agents [8,22-24]. Pre-conditioning of MSCs
with 100 μM SNAP has multiple effects. It significantly
reduced the cyto-pathic effects induced by H2O2 by im-
proving the cell viability and survival in vitro (Figure 1).
Pre-conditioning with SNAP improved the survival and
engraftment of MSCs in ischemic renal tissue (Figure 3).
Pre-conditioning may stimulate endogenous gene ex-
pression which enhanced their engraftment. It has been
reported that NO regulates hemodynamics during renal
organogenesis [25]. During ischemia reperfusion injury,
iNOS is up-regulated and aggravates the renal injury
which may be due to the production of peroxynitrites
[26]. Our in vivo data showed that iNOS expression in
kidney was reduced after pre-conditioned MSCs trans-
plantation. Consequently fibrosis in ischemic renal tissue
was reduced due to decreased collagen deposition in
pre-conditioned MSCs transplanted group (Figure 4).
Akt activates many signaling cascades leading to regu-
lation of a range of critical cellular functions like glucose
metabolism, cell proliferation and survival [27]. NOmediates cyto-protection of isolated islets in serum
deprivation by triggering PI3K/Akt pathway [28]. The
protection mechanism of SNAP pre-conditioned MSCs
seems due to activation of Akt pathway in these cells.
Akt was up-regulated in SNAP pre-conditioned MSCs
resulting in improved cell viability and reduced apop-
tosis in vitro. It enhanced expression of Bcl-2 in kidney
of SNAP pre-conditioned group of animals, inhibiting
apoptosis and facilitates cellular survival in the ischemic
atmosphere of kidney by maintaining mitochondrial
membrane integrity as shown previously [29]. Growth
factors and cytokines play a pivotal role in development,
cell differentiation, survival and proliferation. SNAP pre-
conditioning induced up-regulation of an array of cyto-
protective and pro-angiogenic cytokine and growth fac-
tor genes (IGF-1, SDF-1 and VEGF) in MSCs (Figure 2).
IGF-1, SDF-1 and VEGF are cytoprotective, renotropic
and pro-angiogenic growth factors playing an important
part in vasculogenesis, angiogenesis and chemoattraction
[19,30-33]. Up-regulated expression of VEGF in many
cell types like smooth muscle cells, endothelial cells and
keratinocytes is under the influence of NO [34-37].
VEGF along with Akt enhances the production of NO
by activating eNOS leading to relaxation in endothelium
and increased endothelial permeability which causes
Figure 5 Histology of renal tissue after MSCs transplantation. A: Representative micrographs of renal histology after pre-conditioned MSCs
transplantation. The expression of different pro-survival, pro-angiogenic factors, and proliferation was markedly increased in SNAP group
compared to other treatment groups. Magnification 200x. B: Graphical presentation of Ki- 67 positive nuclei in different treatment groups.
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agreement with the previous studies as in vitro and
in vivo data showed increased VEGF and eNOS expres-
sion in SNAP pre-conditioned MSCs but this responsewas abolished by pre-treating MSCs with methylene
blue. Enhanced expression of VEGF and eNOS may re-
sult in the tissue protection by improved angiogenesis
and perfusion leading to enhanced nutrient supply.
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migration of MSCs [39,40] into the ischemic renal tissue
and their proliferation, but methylene blue treatment
inhibited these factors. This whole milieu of up-
regulated growth factors, chemokine, Bcl-2 and Akt may
favor the maintenance of mitochondrial integrity and
cell survival ensuing to renal protection against
ischemia.
Proliferation is one of the important aspects in cellular
therapies in order to repopulate the damaged tissue. In
our studies, PCNA expression was higher which shows
that SNAP Pre-conditioning elicited proliferation in
MSCs in vitro (Figure 2) [41]. Concurrently, there was
marked increase in Ki-67 expression in tissue sections
from pre-conditioned MSCs transplanted kidneys
(Figure 5A and B) compared to all other treatment
groups showing early make up of cellular loss in kidney
parenchyma resulting in improvement of renal function.
This increase in proliferation activity was diminished by
methylene blue treatment in vitro and in vivo.
Tubular epithelium is lost dramatically in ischemia
reperfusion injury, resulting in impaired kidney function
[42]. Our results demonstrated that mutilation of kidney
function caused by ischemia was overcome by the trans-
plantation of SNAP pre-conditioned MSCs in a better
way by increased creatinine clearance and reduced BUN
(Table 2) which could be due to improved perfusion and
tubulogenesis.Conclusion
This study demonstrates that pharmacological pre-
conditioning of MSCs plays a major part in augmenting
resistance of MSCs to the oxidative stress in vitro and
in vivo injury. Up-regulation of many cytoprotective fac-
tors help MSCs survive better in renal ischemic environ-
ment by activating Akt cell signaling. MSCs’ homing was
improved in ischemic renal tissue leading to enhanced
perfusion and tubulogenesis and improved renal func-
tion. Hence, pre-conditioning can be a potential strategy
to enhance the outcomes of cell based therapies in at-
tenuating renal ischemia injury.Competing interests
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